Search for: "Wyeth Pharmaceuticals" Results 841 - 860 of 971
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al v Abbott… [read post]
6 Sep 2010, 10:21 am by Steve McConnell
Novartis Pharmaceuticals Corp., 2010 U.S. [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al v Abbott… [read post]
12 Feb 2010, 11:21 pm by MacIsaac
Wyeth Pharmaceuticals Inc., 2009 BCCA 592, at para. 12. [14] Section 3 of the CJPTA sets out the circumstances in which a court has territorial jurisdiction as follows: A court has territorial competence in a proceeding that is brought against a person only if: (a)        that person is the plaintiff in another proceeding in the court to which the proceeding in question is a counterclaim, (b)       … [read post]
29 May 2009, 1:28 am
The settlement comes about 10 days after the DOJ announced it would join whistleblower lawsuits against pharmaceutical giant Wyeth. [read post]
13 May 2010, 12:27 pm by Bexis
Wyeth, Inc., 2010 WL 450351 (W.D. [read post]
3 Jun 2010, 1:37 pm by Bexis
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004); White v. [read post]
23 May 2008, 1:03 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Indian Patent Office decisions now searchable and downloadable: (Indian Patent Oppositions), (Generic Pharmaceuticals & IP), (Spicy IP), Institute for Progress study on inter partes re-examination: (Peter Zura's 271 Patent Blog), (IAM), (Hal Wegner) Nintendo loses patent suit over 3D controller; Anascape awarded $21M in damages:… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
18 Nov 2014, 11:16 am
  Indeed, the government has used this ban as the basis for a creeping administrative takeover of pharmaceutical and medical device public relations practices. [read post]
21 Mar 2013, 3:04 pm by Bexis
We were planning to write about the Bartlettoral argument today (we still might) when we learned about Howard v. [read post]